Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty
- 22 April 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8956) , 1013-1016
- https://doi.org/10.1016/s0140-6736(95)90756-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1994
- Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.Journal of Clinical Investigation, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Evaluation of a personal computer-based quantitative coronary analysis system for rapid assessment of coronary stenosesAmerican Heart Journal, 1992
- PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)Nucleic Acids Research, 1992
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Angiotensin and cell growthJournal Of Hypertension, 1991
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJournal of the American College of Cardiology, 1988